相关实验视频

Updated: Feb 6, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

悖论性免疫重建炎症综合征呈现为艾滋病毒患者的肺外结核病

Wendy Shang¹, Tony F Bruno^1,2

¹Department of Biomedical Education, California Health Sciences University College of Osteopathic Medicine, Clovis, USA.

|February 5, 2026

概括

免疫复合炎症综合征 (IRIS) 可以导致感染在免疫恢复期间恶化. 这一案例突出了HIV阳性肺结核患者重新开始高活性抗逆转录病毒治疗 (HAART) 的悖论性TB-IRIS.

科学领域:

免疫学免疫学免疫学
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

免疫复合炎症综合征 (IRIS) 是免疫功能低下个体在免疫恢复期间出现的超炎症反应.
矛盾的IRIS涉及预先存在的感染的恶化,而揭露IRIS揭示了以前未被诊断的感染.
在开始高活性抗逆转录病毒疗法 (HAART) 时,与结核病 (TB) 同感染的晚期艾滋病毒病患者面临高风险的IRIS.

研究的目的:

呈现一个具有悖论性的TB-IRIS病例,该病例发生在一个艾滋病毒阳性患者身上,该患者有结核病史.
为了说明悖论性结核病的临床表现和诊断.
强调在重新启动HAART的同感染患者中识别IRIS的重要性.

主要方法:

在坦桑尼亚北部,一个58岁的女性同时感染艾滋病毒和结核病的案例研究.
分析了临床表现,病史和实验室发现.
诊断是基于临床迹象,症状和与HAART重新启动的时间关系.

主要成果:

这位患者有结核病和艾滋病毒病史,在HAART失效后出现了缓解症和腹.
在重新启动HAART后,她发烧,疲劳和宫淋巴腺炎.
诊断出一种具有悖论性的结核病-IRIS,呈现为结核病淋巴腺炎.

结论:

悖论性结核病-IRIS是重启HAART的HIV-TB共感染患者的显著并发症.
早期识别和诊断对于适当的管理至关重要.
这一案例强调了在资源有限的环境中管理IRIS所面临的挑战.

关键词:

艾滋病毒艾滋病病毒艾滋病毒辅助剂抗逆转录病毒疗法艾滋病毒在撒哈拉以南非洲免疫复合炎症综合征 (iris) 免疫复合炎症综合征结核病 - 虹膜病

更多相关视频

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

相关概念视频

What is the Immune System?

What is the Immune System?

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...